Top Page
Nanosonics Limited
(Sydney:NAN)
Nanosonics Limited (NAN) vs. iShares MSCI Australia ETF (EWA)
Nanosonics Limited Business Overview & Revenue Model
Nanosonics Limited Earnings Call Summary
Nanosonics Limited Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 198.52M | 198.93M | 171.56M | 167.51M | 119.73M | 101.83M |
| Gross Profit | 155.25M | 155.66M | 133.99M | 125.66M | 86.15M | 74.91M |
| EBITDA | 26.04M | 31.82M | 21.72M | 29.50M | 7.86M | 15.75M |
| Net Income | 20.68M | 20.68M | 12.97M | 19.88M | 3.74M | 8.58M |
Balance Sheet | ||||||
| Total Assets | 272.48M | 272.48M | 237.34M | 226.07M | 193.24M | 164.57M |
| Cash, Cash Equivalents and Short-Term Investments | 161.29M | 161.29M | 129.55M | 112.16M | 94.51M | 96.03M |
| Total Debt | 7.69M | 7.69M | 9.30M | 10.72M | 11.71M | 2.49M |
| Total Liabilities | 62.57M | 62.57M | 55.14M | 62.22M | 54.55M | 29.01M |
| Stockholders Equity | 209.91M | 209.91M | 182.20M | 163.86M | 138.69M | 135.57M |
Cash Flow | ||||||
| Free Cash Flow | 35.26M | 35.26M | 20.27M | 19.74M | -271.00K | 5.93M |
| Operating Cash Flow | 43.98M | 43.98M | 22.78M | 23.31M | 6.70M | 7.32M |
| Investing Cash Flow | -8.71M | -8.71M | -2.36M | -3.54M | -6.90M | -1.38M |
| Financing Cash Flow | -3.30M | -3.30M | -3.01M | -2.71M | -1.97M | -1.03M |
Nanosonics Limited Technical Analysis
Nanosonics Limited Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $1.29B | 63.73 | 10.32% | ― | 15.60% | 58.74% | |
72 Outperform | AU$114.11M | 9.38 | 12.37% | 3.58% | -0.74% | 16.65% | |
67 Neutral | AU$164.89M | 26.99 | 12.35% | ― | 39.98% | -30.04% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | AU$70.02M | -5.38 | -31.98% | ― | 34.20% | -23.90% | |
49 Neutral | AU$274.30M | -78.71 | -2.01% | ― | 16.93% | 76.47% | |
47 Neutral | AU$119.74M | -26.79 | -4.28% | ― | 7.38% | 82.39% |
Nanosonics Limited Corporate Events
Nanosonics Limited has announced a daily update regarding its ongoing on-market buy-back program, with a total of 65,909 ordinary fully paid securities bought back on the previous day. This buy-back initiative is part of the company’s strategy to manage its capital structure, potentially enhancing shareholder value and signaling confidence in its financial health.
Nanosonics Limited has announced an update on its ongoing on-market buy-back program, which involves the repurchase of its ordinary fully paid securities. As of the latest update, the company bought back 98,000 securities on the previous day, adding to a total of 192,000 securities repurchased before that. This buy-back initiative reflects the company’s strategic efforts to manage its capital structure and potentially enhance shareholder value.
Nanosonics Limited has announced the application for quotation of 152,842 ordinary fully paid securities on the Australian Securities Exchange (ASX). This move is part of an employee incentive scheme, potentially enhancing employee engagement and aligning their interests with company performance, which could positively impact the company’s operational dynamics and market positioning.
Nanosonics Limited has announced an update regarding its ongoing on-market buy-back program, with a total of 95,000 ordinary fully paid securities bought back on the previous day, adding to the 97,000 securities bought back before that. This buy-back initiative is part of the company’s efforts to manage its capital structure and potentially enhance shareholder value, reflecting a strategic move that may influence its market positioning and stakeholder interests.
Nanosonics Limited has announced an on-market buy-back of its ordinary fully paid securities, as indicated by the ASX security code NAN. This strategic financial move is likely aimed at optimizing the company’s capital structure and could have implications for shareholder value and market perception.
Nanosonics Limited has announced a daily on-market buy-back of its ordinary fully paid securities, as part of its capital management strategy. The buy-back will be conducted through Goldman Sachs, indicating a proactive approach to managing its share capital, which may positively influence investor confidence and market perception.
Nanosonics Limited has announced an update regarding its ongoing on-market buy-back program, with a total of 74,835 ordinary fully paid securities bought back on the previous day, contributing to a cumulative total of 425,624 securities repurchased. This buy-back initiative is part of the company’s strategy to optimize its capital structure and potentially enhance shareholder value.
Nanosonics Limited has announced an update regarding its ongoing on-market buy-back program. As of November 26, 2025, the company has repurchased a total of 425,624 ordinary fully paid securities, including 72,199 securities bought back on the previous day. This buy-back initiative is part of Nanosonics’ strategy to optimize its capital structure and potentially enhance shareholder value.
Nanosonics Limited has announced an update regarding its ongoing share buy-back program. The company reported that it bought back a total of 75,323 ordinary fully paid securities on the previous day, adding to the cumulative total of 74,874 securities bought back prior. This buy-back initiative is part of Nanosonics’ strategy to manage its capital structure effectively, potentially enhancing shareholder value and signaling confidence in the company’s financial health.
Nanosonics Limited has appointed William Haydon as the Regional President for North America, effective December 1, 2025, following the retirement of Ken Shaw. Haydon’s extensive experience in the medical device and healthcare technology sectors, particularly in infection prevention and endoscope reprocessing, aligns with Nanosonics’ strategic priorities as it prepares to commercialize its CORIS® platform, marking a significant step in its growth strategy.
UBS Group AG and its related bodies corporate have ceased to be substantial shareholders of Nanosonics Limited as of November 3, 2025. This change in shareholding could impact the company’s shareholder structure and influence its market perception, potentially affecting investor confidence and the company’s strategic decisions.
Nanosonics Limited held its 2025 Annual General Meeting where all proposed resolutions were successfully carried. The meeting also marked the departure of Dr. Lisa McIntyre from the Board, as previously announced. This outcome reflects strong shareholder support and continuity in the company’s strategic direction, potentially reinforcing its market position and stakeholder confidence.
Nanosonics Limited has announced a $20 million on-market share buy-back program for FY26, reflecting its strong financial position and confidence in long-term growth. This initiative is part of the company’s capital management strategy, supported by its cash reserves and history of predictable cash flows, and aims to deliver long-term value to shareholders while maintaining a strong balance sheet and investing in future growth opportunities.
Nanosonics Limited has announced the application for quotation of 189,870 ordinary fully paid securities on the Australian Securities Exchange (ASX). This move, involving securities issued under an employee incentive scheme, is part of the company’s strategic efforts to enhance its market presence and operational capabilities.
Nanosonics Limited has announced the application for the quotation of 53,069 ordinary fully paid securities on the ASX. These securities are issued under an employee incentive scheme, reflecting the company’s ongoing efforts to incentivize and retain talent, which may enhance its operational capabilities and market position.
Nanosonics Limited has announced its 2025 Annual General Meeting (AGM), which will be held as a hybrid event, allowing shareholders to participate either in person or online. This approach aims to increase accessibility and engagement, enabling shareholders to ask questions and vote in real time, reflecting the company’s commitment to transparency and stakeholder involvement.
Nanosonics Limited announced a change in the director’s interest, specifically regarding Mr. Michael Kavanagh’s holdings. The change involved the exercise of performance and service rights under the Nanosonics Omnibus Equity Plan, resulting in the acquisition of 109,685 ordinary shares. This adjustment in the director’s holdings reflects the company’s ongoing commitment to aligning management interests with shareholder value, potentially impacting investor confidence and market perception.
Nanosonics Limited has announced the issuance of 289,148 ordinary fully paid securities, which will be quoted on the Australian Securities Exchange (ASX). This move is part of an employee incentive scheme, indicating the company’s commitment to rewarding and retaining its workforce, potentially strengthening its market position and operational capabilities.
Nanosonics Limited announced a change in the director’s interest, with Gerard Dalbosco acquiring an additional 12,558 ordinary shares, increasing his total to 40,000 shares. This transaction, valued at approximately $51,231.58, reflects a strategic move in the company’s governance, potentially impacting shareholder confidence and market perception.